This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alhasan, S. A. Articles by Sarkar, F. H. Search for Related Content PubMed PubMed Citation Articles by Alhasan, S. A. Articles by Sarkar, F. H.

Genistein Elicits Pleiotropic Molecular Effects on Head and Neck Cancer Cells

Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201

Genistein (4,5,7-trihydroxyisoflavone) has been reported to induce cell cycle arrest and apoptosis in different cancer cell lines in vitro and to show antitumor activity against a variety of tumors in animal models. We have previously reported (S. A. Alhasan et al., Nutr. Cancer, 34:12–19, 1999; S. A. Alhasan et al., Int. J. Oncol., 16: 333–338, 2000) that genistein induces cell cycle arrest and apoptosis by up-regulating p21^WAF1 and Bax, and down-regulating cyclin B1 and Bcl-2 in a head and neck cancer cell line. However, the precise molecular mechanism(s) by which genistein elicits its effects on head and neck cancer cells still remains to be elucidated. In the present study, we report that genistein induces several specific molecular changes in head and neck cancer cells, such as down-regulation of c-erbB-2 expression, down-regulation of MMP-2 and MMP-9 secretion, inhibition of tumor cell invasion and down-regulation of nuclear factor-B DNA binding activity. In addition, genistein inhibited the levels of phosphorylated Akt and the expression of 14-3-3 protein. Moreover, genistein induces telomere shortening in treated cells without affecting telomerase activity in vitro. We also observed that genistein inhibits the translocation of telomerase catalytic subunit [human telomerase reverse transcriptase (hTERT)] to the nucleus, which may result in telomere shortening, although the activity of telomerase is unaffected, along with the inhibition of metaphase spread of chromosomes. From these results, together with our previously published reports, (S. A. Alhasan et al., Nutr. Cancer, 34: 12–19, 1999; S. A. Alhasan et al., Int. J. Oncol., 16: 333–338, 2000) we conclude that genistein elicits pleiotropic molecular changes that resulting in the inhibition of cell growth and the induction of apoptotic cell death of head and neck cancer cells, which suggests that genistein may be useful as a chemotherapeutic and/or chemopreventive agent for head and neck cancer.

This article has been cited by other articles:

				M. Fan, K. M. Ahmed, M. C. Coleman, D. R. Spitz, and J. J. Li Nuclear Factor-{kappa}B and Manganese Superoxide Dismutase Mediate Adaptive Radioresistance in Low-Dose Irradiated Mouse Skin Epithelial Cells Cancer Res., April 1, 2007; 67(7): 3220 - 3228. [Abstract] [Full Text] [PDF]

				K. Katayama, N. Fujita, and T. Tsuruo Akt/Protein Kinase B-Dependent Phosphorylation and Inactivation of WEE1Hu Promote Cell Cycle Progression at G2/M Transition Mol. Cell. Biol., July 1, 2005; 25(13): 5725 - 5737. [Abstract] [Full Text] [PDF]

				M. F. Aguero, M. M. Facchinetti, Z. Sheleg, and A. M. Senderowicz Phenoxodiol, a Novel Isoflavone, Induces G1 Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21WAF1/CIP1 Cancer Res., April 15, 2005; 65(8): 3364 - 3373. [Abstract] [Full Text] [PDF]

				J. Liao, J. C. Wolfman, and A. Wolfman K-Ras Regulates the Steady-state Expression of Matrix Metalloproteinase 2 in Fibroblasts J. Biol. Chem., August 22, 2003; 278(34): 31871 - 31878. [Abstract] [Full Text] [PDF]

				Y. Li and F. H. Sarkar Gene Expression Profiles of Genistein-Treated PC3 Prostate Cancer Cells J. Nutr., December 1, 2002; 132(12): 3623 - 3631. [Abstract] [Full Text] [PDF]